Zobrazeno 1 - 10
of 266
pro vyhledávání: '"R.A.C. Graham-Brown"'
Autor:
R.A.C. Graham-Brown, Mark F. Healsmith
Publikováno v:
Clinics in Dermatology. 36:282-288
The use of medicinal plants is as old as the hills (and valleys and plains) where they grow. In this brief review, we have set out to emphasize the need for rigor in the assessment of any medicines-whatever their source-as we seek to translate appare
Autor:
H Soran, R. M. Azurdia, Stephen Morris, R Wachsmuth, Richard A Cowan, Sean Whittaker, Eileen Parry, Timothy M Illidge, Eve Gallop-Evans, J. Scarisbrick, M Eagle, R.A.C. Graham-Brown, Anthony S. Wierzbicki, E Wain
Publikováno v:
British Journal of Dermatology. 168:192-200
Summary Background Bexarotene is a synthetic retinoid from the subclass of retinoids called rexinoids which selectively activate retinoid X receptors. It has activity in cutaneous T-cell lymphoma (CTCL) and has been approved by the European Medicines
Autor:
A.B. Alexandroff, R.A.C. Graham-Brown
Publikováno v:
British Journal of Dermatology. 162:12-21
The 67th Annual Meeting of the American Academy of Dermatology took place in San Francisco on 6-10 March 2009. The flavour of this busy but well-organized convention was a mixture of practical, hands-on teaching sessions, led and delivered by experts
Publikováno v:
British Journal of Dermatology. 132:795-799
Summary Nodular prurigo is a distressing disease which is difficult to treat. Two patients with severe nodular prurigo were treated with cyclosporin for periods of 36 and 24 weeks, respectively, using doses of 3–4.5 mg/kg per day. In both cases the
Publikováno v:
British Journal of Dermatology. 132:772-777
A study was undertaken to investigate and compare various methods of estimating the prevalence of atopic dermatitis (AD), and to investigate a possible ethnic difference in our local community. Preschool children attending routine child health survei
Publikováno v:
British Journal of Dermatology. 150:1186-1189
Summary Background In 1989 we demonstrated that 71% of children referred to our paediatric dermatology clinic with atopic dermatitis (AD) had been subject to dietary manipulation by their parents in order to manage their disease. We have re-examined
Autor:
Graham A. Johnston, R.A.C. Graham-Brown, Hidemi Nakagawa, Seth R. Stevens, E.D. Baron, Masahiro Takigawa, M. Kawashima, David A. Barzilai
Publikováno v:
British Journal of Dermatology. 147:710-715
SummaryBackground The incidence of atopic dermatitis (AD) is increasing worldwide. No large-scale study has previously compared the therapeutic management of this condition in different countries. Objectives The purpose of this study was to determine
Autor:
A. Takwale, R.A.C. Graham-Brown, J. Berth-Jones, E. Tan, K. Hotchkiss, G. Barclay, S. Agarwal, I. Ahmed
Publikováno v:
British Journal of Dermatology. 147:324-330
SummaryBackground There is a limited range of treatments for severe atopic dermatitis (AD). Azathioprine has often been used but there has been no randomized controlled trial of this drug to confirm its efficacy in AD. Objectives To establish or refu
Autor:
R.A.C. Graham-Brown
Publikováno v:
Clinical and Experimental Dermatology. 27:328-337
A multicentre clinical trial (Study B313), involving clinicians from countries across Europe, was designed to evaluate the possible role of SDZ-ASM 981 as one part of a long-term strategy in the management of childhood atopic dermatitis (AD). The pri
Autor:
R.A.C. Graham-Brown
Publikováno v:
Clinical and Experimental Dermatology. 36:1-3